SCHEMBL29808205

SCHEMBL29808205

Cc1ccnc(SCc2nc(C3CC3)no2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.42
▸ CRBN Q96SW2 1/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ NPC1 O15118 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ HDAC5 Q9UQL6 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ PKM P14618 1/20 0.37
▸ HTT P42858 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29808310 0.95 ALOX15 (0.40) ALOX15CRBNKMT2ANPC1RAB9A
SCHEMBL29807963 0.95 ALOX15 (0.40) ALOX15CRBNKMT2ANPC1RAB9A
SCHEMBL27218745 0.79 RAB9A (0.50) ALOX15KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL29808161 0.76 ALOX15 (0.43) ALOX15KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL29807808 0.74 TSHR (0.61) KMT2ANPC1RAB9ASMN1; SMN2MEN1
SCHEMBL31494451 0.74 RAB9A (0.48) ALOX15KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL27218791 0.74 RAB9A (0.48) ALOX15KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL18507237 0.74 MEN1 (0.41) KMT2AMEN1GAAHDAC1HDAC8
SCHEMBL31494372 0.73 SMN1; SMN2 (0.49) KMT2ANPC1RAB9ASMN1; SMN2MEN1
SCHEMBL29808248 0.72 NPC1 (0.46) ALOX15KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220274968-A1 Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 GBIOTECH S.À.R.L. (CH) 2022-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220274968-A1 Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 FFAR2, FFAR1, FFAR3 ALOX15 111/4885CRBN 4797/4885KMT2A 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback